Please use this identifier to cite or link to this item:
Title: MS-Driven Metabolic Alterations Are Recapitulated in iPSC-Derived Astrocytes
Authors: GHIROTTO, BrunoOLIVEIRA, Danyllo F.CIPELLI, MarcellaBASSO, Paulo J.LIMA, JeanBREDA, Cristiane N. S.RIBEIRO, Henrique C.SILVA, Camille C. C.SERTIE, Andrea L.OLIVEIRA, Antonio Edson R.I, Meire HiyaneCALDINI, Elia G.SUSSULINI, AlessandraI, Helder NakayaKOWALTOWSKI, Alicia J.OLIVEIRA, Enedina M. L.ZATZ, MayanaCAMARA, Niels O. S.
Citation: ANNALS OF NEUROLOGY, v.91, n.5, p.652-669, 2022
Abstract: Objective Astrocytes play a significant role in the pathology of multiple sclerosis (MS). Nevertheless, for ethical reasons, most studies in these cells were performed using the Experimental Autoimmune Encephalomyelitis model. As there are significant differences between human and mouse cells, we aimed here to better characterize astrocytes from patients with MS (PwMS), focusing mainly on mitochondrial function and cell metabolism. Methods We obtained and characterized induced pluripotent stem cell (iPSC)-derived astrocytes from three PwMS and three unaffected controls, and performed electron microscopy, flow cytometry, cytokine and glutamate measurements, gene expression, in situ respiration, and metabolomics. We validated our findings using a single-nuclei RNA sequencing dataset. Results We detected several differences in MS astrocytes including: (i) enrichment of genes associated with neurodegeneration, (ii) increased mitochondrial fission, (iii) increased production of superoxide and MS-related proinflammatory chemokines, (iv) impaired uptake and enhanced release of glutamate, (v) increased electron transport capacity and proton leak, in line with the increased oxidative stress, and (vi) a distinct metabolic profile, with a deficiency in amino acid catabolism and increased sphingolipid metabolism, which have already been linked to MS. Interpretation Here we describe the metabolic profile of iPSC-derived astrocytes from PwMS and validate this model as a very powerful tool to study disease mechanisms and to perform non-invasive drug targeting assays in vitro. Our findings recapitulate several disease features described in patients and provide new mechanistic insights into the metabolic rewiring of astrocytes in MS, which could be targeted in future therapeutic studies. ANN NEUROL 2022
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MPT
Departamento de Patologia - FM/MPT

Artigos e Materiais de Revistas Científicas - LIM/59
LIM/59 - Laboratório de Biologia Celular

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.